Wednesday, December 10th, 2025: Day Two - ET (Eastern Time, GMT-05:00)
This session is designed for attendees who are new to their role, new to the industry or new to their company and looking for a foundational course on the foundational knowledge needed for success.
Understand of trade and channel management for market access and product distribution
Delve into the governing regulatory landscape, including the Drug Supply Chain Security Act (DSCSA) and other relevant regulations
Learn and discuss about building and maintaining effective partnerships with internal and external channel stakeholders
Engage and network with colleagues also new to trade and learn from specific case examples of what has worked and what hasn’t
- Christine Hummel - US Head, Trade & Channel Management, Sanofi
Discover how new working models are transforming the pharmacy industry
Understand enhanced efficiency and flexibility through remote work models
Improve decision-making and patient care with AI-driven solutions
Gain practical strategies to future-proof pharmacy operations
- Amanda Salindong - Associate Director, Channel and Distribution, Alnylam
Understand current traceability requirements
Develop effective strategies to protect supply chain integrity, and combat counterfeiting through serialization capabilities
Explore methods to transform business through enhanced inventory management and data-driven insights
- Michael Rowe - Senior Director, DSCSA and Serialization Services, TwoLabs Pharma Services
Explore the specialized supply chain requirements and distribution challenges unique to complex administration products, including cold chain management, limited network distribution and inventory optimization strategies
Understand the evolving landscape of home-based administration services, including nursing requirements, training protocols and innovative approaches to overcome reimbursement hurdles for specialized care delivery
Learn effective frameworks for identifying, evaluating, and collaborating with specialized administration organizations
Explore innovative approaches to unifying multiple digital touchpoints, from telehealth platforms and patient portals to remote monitoring tools and EHR systems and more
Learn from pioneering case studies where AI applications have successfully bridged communication gaps between pharmaceutical companies and health systems, enabling more personalized interventions, streamlined medication management and data-informed care delivery
- Shefali Shah - Director, Market Access Health Innovation, Specialty Care, Sanofi
In this advanced session, connect with fellow trade, channel and distribution experts, to share experiences and benchmark on common challenges. Take part in this critical, interactive knowledge-exchange in an open, collaborative format.
**This summit is an exclusive, senior-level benchmarking discussion. Attendees should have a minimum of 7 years’ experience in trade and channel strategies and must currently be employed at life science manufacturer. Informa Connect reserves the right to qualify participants for this Summit during this time. Please email Alexandra.spica@informa.com to reserve your seat.
- Rena K. Goins - Executive Director, Global Trade, Regeneron
When launching a new product, designing the right distribution network is critical to success. This session guides participants through the key considerations and decision-making processes involved in creating a network.
Evaluate product usage patterns and special handling requirements before committing to a network design
Understand that not all trade strategies are the same and tailoring your approach accordingly
Build the right team and crafting customized solutions to support your network
Define the scope and performance expectations of your network to ensure it aligns with your goals that meets the unique needs of your product.
- Tami Carten - Vice President of Trade and Patient Support, Braeburn
Gain actionable insights on scenario planning and forecasting methodologies to position your portfolio optimally in the post-IRA landscape
Learn practical approaches to accelerate value creation earlier in product lifecycles and leverage emerging technologies to thrive despite economic constraints
Understand the different navigation pathways for drugs selected for negotiation
- Sopheap Dijhanian - Director, Riparian LLC
Analyze the impact of tariffs and current policies affecting supply chains and competitive positioning
Evaluate what operations to bring onshore versus maintain internationally
Gain practical approaches for organizations with limited global trade resources
Develop frameworks for identifying and addressing trade-related risks
Explore the complex reality of drug shortages in today's healthcare landscape and address the very real challenges faced by healthcare providers
Discuss how to track shortage data, communicate with manufacturers and help members navigate supply disruptions
- Fred Pane - Vice President, Capstone Health Alliance
- Christopher Lisanti - Managing Director, Commercial Advisory Group – Consulting, Head, Customer and Digital Engagement, Syneos Health Consulting
Building scalable 3PL partnerships for diverse product portfolios
Aligning account operations with field sales to enhance customer experience
Best practices for improving access and operational efficiency in complex distribution models
- Robert Blauvelt - Associate Director of Channel and Account Operations, Pacira BioSciences
Analyze drop-ship versus full-line wholesale distribution approaches, including real-world cost implications, inventory management considerations and impact on patient access
Illuminate the complex interplay between manufacturers, specialty pharmacies, providers and payers
Examine how distribution choices affect each stakeholder differently, from health systems managing limited storage capacity to specialty pharmacies balancing inventory risk
- John Bullock, MBA - Senior Director, Trade, Distribution & GPO, UroGen Pharma
- Charlie Beck - Director, Supply Chain, UroGen Pharma
The landscape of life sciences is rapidly evolving with the increasing adoption of generics and biosimilars. This session equips you with actionable strategies to navigate this competitive environment and achieve sustainable growth.
Delve into the current state of generics and biosimilars adoption, highlighting key trends and market segments with high growth potential
Learn how to effectively position products against competitors, navigate payer negotiations and secure favorable reimbursement decision
Discuss how health systems are approaching generics and biosimilars, and how to tailor approaches to meet evolving needs and priorities
Gain insights into emerging trends and technologies that will shape the future of generics and biosimilars, allowing you to stay ahead of the curve
- Nick Rausch - Vice President of Trade and National Accounts, BioCareSD
- Ryan Cort - Senior Director, Generics & Biosimilars Trade Relations, BioCare, Inc
Examine current customs compliance requirements, country of origin concerns through recent case studies
Understand enforcement priorities and risk management approaches to avoid potential pitfalls
Implement an effective industry playbook by understanding the compliance continuum from manufacturer to pharmacy endpoint responsibilities
- Tom Scalone - Senior Director, Trade Strategy and Operations, Bristol Myers Squibb
Measure and manage delivery success with metrics that matter most to the patient
Identify where and why risks emerge, and resolve with targeted supply chain improvements
Quantify the benefits of a more robust, less risky delivery network
- Jay McHarg - CEO, AeroSafe Global
Harness the power of distribution analytics for competitve advantage
Benchmarking methodologies to evaluate efficency and performacne measurement across differnet models
Transform data into strategic action
- Steven Projansky - Director, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc.
Master the complexities of payer relationships, reimbursement methodologies and formulary decision-making processes that drive market access success
Develop expertise in financial structures, budget impact modeling and risk-sharing arrangements to create mutually beneficial partnerships
Identify high-value partnership models that address health system challenges while improving patient outcomes and optimizing pharmaceutical value propositions
- John Robicsek - AVP Strategy, Business and Program Development Pharmacy Administration Specialty Pharmacy Service, Advocate Health
Understand why limited distribution networks may work best for rare disease medications
Connect hub services with specialty pharmacies to streamline patient support and access
Assess challenges working with health systems and medical centers when they are outside of traditional distribution channels
- Danielle Bryan - Program Director, Trade Relations and Market Access, Vanderbilt University Medical Center
Orphan drug commercialization challenges the conventions of scale, logistics and patient access. With small patient populations, urgent timelines and high provider education needs, traditional 3PL models often fall short.
In this session, distribution and trade leaders share insights into how purpose-built 3PL strategies can support the unique dynamics of rare and orphan therapies. Drawing on real-world experience, they’ll explore:
What orphan drug manufacturers should look for in a 3PL — beyond cold chain and inventory
How integrated teams and shared data improve access and visibility for niche patient populations
The critical role of agility, transparency and communication in ensuring successful therapy adoption
Lessons learned from building high-touch distribution frameworks that prioritize outcomes over volume
- Kevin Kissling - Vice President and General Manager, 3PL Services, LogiCare3PL
- Ryan Grimmett - Vice President, Logicare3PL Strategy & Business Development, LogiCare3PL
This empowering session explores the unique experiences, challenges and opportunities for women in the trade industry. Participants will gain valuable insights into creating inclusive environments, pursuing professional development and charting successful career trajectories in traditionally male-dominated trade sectors. Key topics to be discussed include:
- Building inclusive teams in trade
Professional development pathways specifically relevant to women in trade
Charting your career path
Inspirational journeys from those who have pioneered paths in trade
- Lisa Arthurs - Vice President, Trade, TwoLabs Pharma Services
- Eliane Maalouf - Director of Trade and Fulfillment – Specialty Pharmacy, Mass General Brigham
- Amanda Salindong - Associate Director, Channel and Distribution, Alnylam
- Dana Dickens - Senior Director, Trade, Gilead Sciences
- Martine Avello - Director, Channel & Distribution, BioMarin Pharmaceutical Inc.
- Rena K. Goins - Executive Director, Global Trade, Regeneron